Jaclyn Bjorklund of Louisiana accuses Novo Nordisk, the maker of Ozempic, and Eli Lilly, which makes Mounjaro, another Type 2 diabetes treatment being used off-label for weight loss, of failing to warn or adequately warn of all the possible adverse side effects from using the medications, including the risk of gastroparesis, also known as paralyzed stomach. Bjorklund, 44, was diagnosed with Type 2 diabetes in 2017 and used Ozempic for more than one year, then stopped and switched to Mounjaro in July 2023 with both drugs prescribed by her doctors to control her blood sugar, according to court papers
If you are unsure what to do after missing a dose or have missed multiple doses, contact your GP or diabetes specialist nurse for advice
Visit the following pages for more information on semaglutide for weight loss, as well as the other medical spa services available at IconMD
The current study aim was to put these visual presentations into a demonstration format to explore if and to what extent they convey new or useful information beyond traditional graphical and tabular approaches
PRRX2 promotes GSC maintenance [53] while GCH1-derived tetrahydrobiopterin (BH4) exerts antioxidant effects through lipid remodeling [54, 55]
